logo

Breaking News

Share

Biogen Inc. (BIIB) announced the Committee for Medicinal Products for Human Use has recommended granting marketing authorization for VUMERITY in the European Union. VUMERITY is a next-generation oral fumarate for the treatment of adults with relapsing-remitting multiple sclerosis. The company said...

Corcept Therapeutics Inc. (CORT) said that results from its 178-patient, randomized, controlled, Phase 2 trial of relacorilant plus nab-paclitaxel in patients with recurrent platinum-resistant ovarian cancer were featured in a proffered paper oral presentation at the European Society for Medical Oncology...

United Airlines (UAL) said it will begin new service between Washington, D.C. and Lagos, Nigeria on November 29. The company noted that this flight is the only service between the U.S. and Nigeria to offer premium economy product. The airline will operate three weekly flights, and tickets will be...

Chico's FAS, Inc. (CHS) announced the appointment of Patrick Guido as Chief Financial Officer, effective September 20, 2021. Patrick Guido most recently served as Senior Vice President and Chief Financial Officer at Asbury Automotive Group, Inc. Prior to this role, Guido served as Executive Vice President...

Merck & Co., Inc. (MRK) said that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of KEYTRUDA, Merck's anti-PD-1 therapy, in combination with chemotherapy for the treatment of locally recurrent unresectable or metastatic triple-negative...

MasterCraft Boat Holdings, Inc. (MCFT) said the company is revising first quarter guidance due principally to a temporary delay in the shipment of a key component from a single engine parts supplier for the MasterCraft brand. The company reaffirmed its guidance for fiscal 2022. "By working closely...

Jackson Financial Inc. (JXN) reported an improved second-quarter adjusted operating earnings due largely to strong private equity investment returns and separate account growth. Jackson separated from Prudential plc on September 13, 2021, and the results mark the company's first quarterly earnings report...

Deciphera Pharmaceuticals Inc. (DCPH) said that the European Medicines Agency's or EMA Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Qinlock or ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumor...

Insurer Progressive Corp. (PGR) reported Friday a net loss for the month of August of $6.6 million or $0.02 per share, compared to net income of $487.4 million or $0.83 per share in the prior-year month. Meanwhile, net premiums written for the month grew 13 percent to $3.89 billion from $3.44 billion...

Novartis (NVS) announced findings from a real-world study, which evaluated the safety and efficacy of alpelisib for people living with PIK3CA-Related Overgrowth Spectrum or PROS who received treatment daily for at least 24 weeks. Results from EPIK-P1 showed alpelisib effectively reduced volume of...

Enveric Biosciences (ENVB), a biotechnology company developing cannabinoid medicines, on Friday announced the closing of its acquisition of privately held MagicMed Industries Inc. With the acquisition, Enveric intends to build a pipeline of proprietary psychedelic assets through MagicMed's molecular...

TCR2 Therapeutics Inc. (TCRR) announced positive interim results from the ongoing phase 1 portion of the gavo-cel phase 1/2 clinical trial for mesothelin-expressing solid tumors. The company is very encouraged by the progression free survival and overall survival observed among patients with refractory...

AstraZeneca PLC (AZN, AZN.L) said Friday that results from the large, randomized COAST Phase II trial showed oleclumab, an anti-CD73 monoclonal antibody, or monalizumab, an anti-NKG2A monoclonal antibody, in combination with Imfinzi or durvalumab improved progression-free survival or PFS and objective...

Roche (RHHBY) said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended the approval of Gavreto (pralsetinib) as a monotherapy for the treatment of adult patients with rearranged during transfection fusion-positive advanced non-small cell lung cancer not previously...

Manchester United (MANU) announced Friday a fourth-quarter net loss of 107.7 British pounds or 66.08 pence per basic share, sharply wider than 36.5 pounds or 22.36 pence per basic share in the prior-year quarter. Excluding items, adjusted loss per basic share for the quarter was 20.67 pence, compared...

Follow RTT